Andrew Pumerantz

Andrew Pumerantz is a Professor at Western University of Health Sciences' College of Osteopathic Medicine of the Pacific (WesternU/COMP) with appointments in Population Health Science, Internal Medicine, and Infectious Disease. He directs the Department of Population Health Science and co-directs the DO/MPH Dual Degree Program at CGU/SCGH. His career spans clinical practice as an infectious disease specialist, academic leadership, and translational research.

• Education: AB from Occidental College, DO from Philadelphia College of Osteopathic Medicine, MPH from UC Berkeley
• Clinical training: Internal Medicine residency at Beth Israel Medical Center, Infectious Diseases fellowship at Yale

Research focuses on population health disparities, diabetes phenotypic heterogeneity, and novel antimicrobial therapies. His work includes co-patenting pegylated liposomal vancomycin for MRSA pneumonia and creating the Diabetes Cross-Disciplinary Index (DXDI©) for standardized diabetes care.

Scientific awards include:

• Fellow of the American College of Physicians
• Honorary Member of Delta Omega Honorary Society in Public Health

He has published extensively in journals like Antimicrobial Agents and Chemotherapy, Diabetologia, and BMJ Open Diabetes Research & Care, with recent work centered on person-centric diabetes outcomes and interdisciplinary screening protocols.